Clinical trial
Varenicline Versus Cytisine for Smoking Cessation in the Primary Care Setting in Croatia and Slovenia - a Randomized Controlled Trial
NCT04015414 is registered in ClinicalTrials.gov with University of Zagreb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Varenicline Versus Cytisine for Smoking Cessation in the Primary Care Setting in Croatia and Slovenia - a Randomized Controlled Trial
- Lead sponsor
- University of Zagreb
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 14, 2020
- Completion date
- November 1, 2022
- Enrollment
- 352 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation